Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?
about
Trial watch - inhibiting PARP enzymes for anticancer therapyFamily-wide chemical profiling and structural analysis of PARP and tankyrase inhibitorsSam68 Is Required for DNA Damage Responses via Regulating Poly(ADP-ribosyl)ationMolecular targeting of glioblastoma: Drug discovery and therapiesPARP inhibition delays progression of mitochondrial encephalopathy in mice.Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition.Poly(ADP-ribose) polymerase inhibitors as promising cancer therapeutics.The role of poly adenosine diphosphate ribose polymerase inhibitors in breast and ovarian cancer: current status and future directions.PARP inhibitors: mechanism of action and their potential role in the prevention and treatment of cancer.PARP inhibitors in cancer therapy: an update.Therapeutic Targeting of Poly(ADP-Ribose) Polymerase-1 (PARP1) in Cancer: Current Developments, Therapeutic Strategies, and Future Opportunities.PARP inhibitors as antitumor agents: a patent update (2013-2015).Effect of p53 activity on the sensitivity of human glioblastoma cells to PARP-1 inhibitor in combination with topoisomerase I inhibitor or radiation.Axin1 expression facilitates cell death induced by aurora kinase inhibition through PARP activation.PARP1 in Carcinomas and PARP1 Inhibitors as Antineoplastic Drugs.
P2860
Q26745673-5DBA0D75-D712-4648-BED9-DB4DB31E4A82Q27677345-5C1A758D-785E-4E52-B7C4-1D685BF71A8BQ28554210-8C77D34C-F103-48DF-974D-ADAB7D5ACA7AQ33911283-07E9DD7D-B686-4385-8467-B846EDA5F92FQ34000773-4C26A2DC-6D65-4FFB-832D-1AF14F8E5A2FQ36905632-912A34B5-4D53-4351-8023-8BF1C1257468Q37727996-EE71E3A6-B3D1-4085-A459-36F7B57DD74DQ37925127-63BED675-0493-459B-A17B-A6045CD7272CQ38029726-A6769489-F850-406D-B60C-242953638589Q38078993-0A5726C1-4207-473B-9452-B2ACB2200197Q38683171-78423E4C-AF65-4720-B7CA-3EF856FB8288Q38795712-223AAC7F-C452-4597-AF81-8E892569CCE0Q38960333-F91EDD21-5F7A-4CCC-BC9A-749EE0D00D70Q39552816-D4153A25-9294-4DBE-B0B9-E4B47A6F612DQ43042008-3D37D31C-FCF2-42C2-9C02-AD381741F6B1
P2860
Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?
@en
type
label
Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?
@en
prefLabel
Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?
@en
P2093
P2860
P1476
Poly(ADP-ribose) polymerase inhibition in cancer therapy: are we close to maturity?
@en
P2093
Alessandra Scolaro
Alessia Montagnoli
Barbara Forte
Claudia Perrera
Helena Posteri
Paolo Orsini
P2860
P304
P356
10.1517/13543770903215883
P407
P577
2009-10-01T00:00:00Z